12:00 AM
 | 
Apr 09, 2015
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Claudin 1 (CLDN1)

Infectious disease

INDICATION: Hepatitis C virus (HCV)

Mouse studies suggest anti-CLDN1 antibodies could help treat chronic HCV infection. In a humanized mouse model of HCV infection challenged with multiple HCV genotypes, pretreatment...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >